<?xml version="1.0" encoding="UTF-8"?>
<p>Xiong et al. (2020) reported that SARS-CoV-2 spike RBD domain specific antibody was generated from immunized BALB/c mouse with SARS-CoV-2 spike RBD domain protein. With this study, mAbs against SARS-COV-2 RBD were produced using hybridoma technology. </p>
